351 related articles for article (PubMed ID: 17997710)
1. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenic protein 2 activates protein kinase D to regulate histone deacetylase 7 localization and repression of Runx2.
Jensen ED; Gopalakrishnan R; Westendorf JJ
J Biol Chem; 2009 Jan; 284(4):2225-34. PubMed ID: 19029091
[TBL] [Abstract][Full Text] [Related]
3. Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/WAF1) promoter.
Westendorf JJ; Zaidi SK; Cascino JE; Kahler R; van Wijnen AJ; Lian JB; Yoshida M; Stein GS; Li X
Mol Cell Biol; 2002 Nov; 22(22):7982-92. PubMed ID: 12391164
[TBL] [Abstract][Full Text] [Related]
4. Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expression.
Lamour V; Detry C; Sanchez C; Henrotin Y; Castronovo V; Bellahcène A
J Biol Chem; 2007 Dec; 282(50):36240-9. PubMed ID: 17956871
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.
Schroeder TM; Kahler RA; Li X; Westendorf JJ
J Biol Chem; 2004 Oct; 279(40):41998-2007. PubMed ID: 15292260
[TBL] [Abstract][Full Text] [Related]
6. HDAC3 and HDAC7 have opposite effects on osteoclast differentiation.
Pham L; Kaiser B; Romsa A; Schwarz T; Gopalakrishnan R; Jensen ED; Mansky KC
J Biol Chem; 2011 Apr; 286(14):12056-65. PubMed ID: 21324898
[TBL] [Abstract][Full Text] [Related]
7. p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation.
Jensen ED; Niu L; Caretti G; Nicol SM; Teplyuk N; Stein GS; Sartorelli V; van Wijnen AJ; Fuller-Pace FV; Westendorf JJ
J Cell Biochem; 2008 Apr; 103(5):1438-51. PubMed ID: 17960593
[TBL] [Abstract][Full Text] [Related]
8. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R
J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110
[TBL] [Abstract][Full Text] [Related]
9. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
[TBL] [Abstract][Full Text] [Related]
10. Foxo1 mediates insulin-like growth factor 1 (IGF1)/insulin regulation of osteocalcin expression by antagonizing Runx2 in osteoblasts.
Yang S; Xu H; Yu S; Cao H; Fan J; Ge C; Fransceschi RT; Dong HH; Xiao G
J Biol Chem; 2011 May; 286(21):19149-58. PubMed ID: 21471200
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase co-repressor complex control of Runx2 and bone formation.
Jensen ED; Nair AK; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2007; 17(3):187-96. PubMed ID: 17725488
[TBL] [Abstract][Full Text] [Related]
12. EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma-Induced Epigenetic Suppression of Osteoblast Differentiation.
Adamik J; Jin S; Sun Q; Zhang P; Weiss KR; Anderson JL; Silbermann R; Roodman GD; Galson DL
Mol Cancer Res; 2017 Apr; 15(4):405-417. PubMed ID: 28119431
[TBL] [Abstract][Full Text] [Related]
13. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.
Dressel U; Bailey PJ; Wang SC; Downes M; Evans RM; Muscat GE
J Biol Chem; 2001 May; 276(20):17007-13. PubMed ID: 11279209
[TBL] [Abstract][Full Text] [Related]
14. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
Jeong HM; Choi YH; Lee SH; Lee KY
Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
[TBL] [Abstract][Full Text] [Related]
15. Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3.
Kang JS; Alliston T; Delston R; Derynck R
EMBO J; 2005 Jul; 24(14):2543-55. PubMed ID: 15990875
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase inhibitors promote osteoblast maturation.
Schroeder TM; Westendorf JJ
J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer.
Khalid O; Baniwal SK; Purcell DJ; Leclerc N; Gabet Y; Stallcup MR; Coetzee GA; Frenkel B
Endocrinology; 2008 Dec; 149(12):5984-95. PubMed ID: 18755791
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
19. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program.
Hassan MQ; Gordon JA; Beloti MM; Croce CM; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19879-84. PubMed ID: 20980664
[TBL] [Abstract][Full Text] [Related]
20. Orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) protein negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation through suppressing runt-related gene 2 (Runx2) activity.
Lee KN; Jang WG; Kim EJ; Oh SH; Son HJ; Kim SH; Franceschi R; Zhang XK; Lee SE; Koh JT
J Biol Chem; 2012 Jun; 287(23):18888-99. PubMed ID: 22493443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
